Albert B. Sabin Vaccine Institute
Clinical trials sponsored by Albert B. Sabin Vaccine Institute, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New marburg vaccine trial aims to stop deadly virus Results expected Oct 2026 (estimated)
- New sudan ebola vaccine moves to phase 2 trial in healthy adults Results expected Feb 2027 (estimated)
-
New sudan ebola vaccine moves to phase 2 trial in healthy adults
Vaccine OngoingThis study tests an experimental vaccine against Sudan ebolavirus in 200 healthy adults aged 18 to 70. The vaccine uses a harmless chimpanzee virus to deliver protection. Researchers will check for side effects and measure immune responses 29 days after vaccination. The goal is t…
Phase 2 • Sponsor: Albert B. Sabin Vaccine Institute • Aim: Vaccine
Last updated Jun 27, 2026 09:03 UTC
-
New marburg vaccine trial aims to stop deadly virus
Vaccine OngoingThis study tests an experimental vaccine against Marburg virus, a rare but severe disease. About 200 healthy adults will receive either the vaccine or a placebo to check for side effects and measure immune responses. The goal is to see if the vaccine is safe and prompts the body …
Phase 2 • Sponsor: Albert B. Sabin Vaccine Institute • Aim: Vaccine
Last updated Jun 27, 2026 08:14 UTC